Osteoporosis Treatment Market Size, Top Players, and Forecast by 2031
Osteoporosis Treatment Market: Strategic Insights
Osteoporosis Treatment Market
-
CAGR (2023 - 2031)3.8% -
Market Size 2023
US$ 16.83 Billion -
Market Size 2031
US$ 22.72 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing Cases of Osteoporosis and Modifications in Lifestyle
- Growing Awareness and Diagnosis of Osteoporosis
FUTURE TRENDS
- Increasing Research and Development (R&D) for New Drug Candidates
OPPORTUNITIES
- Growing Digital Health Solutions
Key Players
- Pfizer Inc
- Amgen Inc
- Cadila Pharmaceuticals
- Eli Lilly and Company
- Daiichi Sankyo Company Limited
- Teva Pharmaceuticals Inc
- Asahi Kasei Corporation
- Novartis AG
- Chugai Pharmaceutical Co Ltd
- Teijin Pharma Limited
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Drug Class - Calcitonin
- Bisphosphonates
- Selective Estrogen Receptor Modulators
- PTH-Related Anabolic
Type - Primary Osteoporosis
- Secondary Osteoporosis
Route of Administration - Oral
- Injectable
Distribution Channel - Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Get Free Sample For